Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Xinjiang Institute of Materia Medica is a specialized research and development organization dedicated to the study and modernization of Traditional Uighur Medicine (TUM). Founded in 1974 and based in Urumqi, the institute focuses on extracting bioactive compounds from the unique medicinal plants found in the Xinjiang region. Its research portfolio spans drug discovery, pharmacology, and clinical evaluation, with a particular emphasis on treatments for vitiligo, respiratory ailments, and cardiovascular diseases. The institute operates the Xinjiang Key Laboratory of Uighur Medicine, serving as a central hub for ethnic medicine innovation in China. By integrating traditional knowledge with modern pharmaceutical technology, it has successfully brought several proprietary ethnic drugs to the commercial market. The organization also provides technical services and quality control standards for the regional pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 新疆维吾尔自治区药物研究所.